Evidence map›Paper›PMID 32411478›Full record

ArticleProstate cancer2020

Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program.

Dariga S Smailova, Elisa Fabbro, Serik E Ibrayev, Luca Brusati, Yuliya M Semenova, Umutzhan S Samarova, Farida S Rakhimzhanova, Sabit M Zhussupov, Zaituna A Khismetova, Hengameh Hosseini

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Prostate cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Trends of Prostate Cancer Morbidity in Low-Incidence Countries from 1990-2019.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Dariga S SmailovaSemey Medical University, Semey, Kazakhstan.ORCID https://orcid.org/0000-0002-7152-7104
Elisa FabbroDepartment of Medicine, Udine University, Udine, Italy.
Serik E IbrayevPublic Health Department, Astana Medical University, Nur-Sultan, Kazakhstan.
Luca BrusatiDepartment of Economics and Statistics, Udine University, Udine, Italy.
Yuliya M SemenovaSemey Medical University, Semey, Kazakhstan.
Umutzhan S SamarovaSemey Medical University, Semey, Kazakhstan.
Farida S RakhimzhanovaSemey Medical University, Semey, Kazakhstan.
Sabit M ZhussupovSemey Medical University, Semey, Kazakhstan.
Zaituna A KhismetovaSemey Medical University, Semey, Kazakhstan.
Hengameh HosseiniDepartment of Health Administration, University of Scranton, Scranton, PL, USA.ORCID https://orcid.org/0000-0002-3142-1102
Semey Medical University · KZUniversity of Udine · ITAstana Medical University · KZUniversity of Scranton · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32411478
PMCPMC7204116
OpenAlexW3004133975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.